The Lankenau Institute for Medical Research
Business Development at the Lankenau Institute for Medical Research focuses on three main functions.
In addition, LIMR has established two core facilities, the LIMR Chemical Genomics Center (LCGC) and the Center for Human Antibody Technology (CHAT), both community resources initially funded through Keystone Innovation Grants.
George C. Prendergast, PhD
President, CEO and Professor